New Insights into Microglia's Role in Clearing Amyloid Beta in Alzheimer’s Disease
Discover how microglia, the brain's immune cells, use a specific receptor to efficiently clear amyloid beta proteins, offering potential new strategies for Alzheimer’s disease treatment.
Research conducted by scientists at the University of California, San Francisco has uncovered a crucial mechanism by which microglia, the brain's immune cells, help combat Alzheimer's disease. In Alzheimer's, abnormal proteins like amyloid beta tend to form sticky clumps called plaques that can damage brain cells and lead to cognitive decline. Interestingly, some individuals naturally possess microglia capable of efficiently degrading these toxic proteins, resulting in fewer and smaller plaques and milder symptoms.
The study identified a specific molecular receptor, ADGRG1, which enables microglia to effectively engulf and break down amyloid beta. In experiments with mouse models lacking this receptor, researchers observed a rapid accumulation of amyloid plaques, increased neurodegeneration, and deficits in learning and memory. Conversely, when the receptor functions properly, microglia help maintain brain health by cleaning up amyloid beta before it causes extensive damage.
Further analysis of human brain tissue revealed that individuals with mild Alzheimer’s had higher levels of ADGRG1 expression in their microglia compared to those with severe Alzheimer’s, indicating a protective role for this receptor in disease progression. Since ADGRG1 is a G protein-coupled receptor, a common target in drug development, this discovery opens new avenues for therapies aimed at boosting microglial activity against amyloid beta.
Dr. Xianhua Piao of UCSF emphasized that this receptor helps microglia perform their vital role in maintaining brain health over many years. This research provides hope that future drugs could enhance microglia’s ability to clear amyloid beta, potentially slowing or preventing the progression of Alzheimer’s disease.
Source: https://medicalxpress.com/news/2025-07-microglia-engulf-amyloid-beta-protein.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Preventing Glaucoma-Related Vision Loss: Barriers to Care and the Need for Accessible Treatment
Glaucoma is a leading cause of blindness, but many are unable to afford the treatment needed to prevent vision loss. Barriers include high medication costs and limited access to care, especially in underserved communities. Efforts by charities and healthcare reforms are vital to address these disparities and protect eye health.
Innovative Reversible Technique Targets Neural Circuits with Molecular Precision
A pioneering technique enables reversible, precise disruption of brain neural circuits using engineered proteins, opening new avenues for neuroscience research and potential therapies for neurological disorders.
Study Reveals Elevated Stroke Risk Among Native Hawaiian and Pacific Islander Populations
Research shows Native Hawaiian and Pacific Islander communities face the highest stroke rates in the U.S., emphasizing the need for targeted health interventions and better data collection.
Prenatal Alcohol Exposure May Impair Stroke Recovery in Midlife
Prenatal alcohol exposure can have lasting health effects, including worsening stroke recovery in middle age. New research underscores the importance of early-life factors in determining long-term cerebrovascular health.